{
    "applicationNumber": "BR 11 2020 024512-7",
    "filingDate": "24/05/2019",
    "grantDate": null,
    "title": "ANTICORPO ANTI-INTERLEUCINA-17A, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, E, USO DOS MESMOS",
    "nationalPhaseDate": [
        "30/11/2020"
    ],
    "internationalApplication": {
        "pctNumber": "PCT CN2019/088344",
        "pctDate": "24/05/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "CN",
            "priorityNumber": "201810539405.0",
            "priorityDate": "30/05/2018"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2606"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2617"
        },
        {
            "code": "15.35",
            "description": "Atualiza\u00e7\u00e3o de informa\u00e7\u00f5es no portal",
            "bulletinNumber ": "2658"
        }
    ],
    "inventors": [
        "BAIYONG LI",
        "YU XIA",
        "ZHONGMIN MAXWELL WANG",
        "PENG ZHANG"
    ],
    "holders": [
        236783
    ],
    "ipcCodes": [
        "A61P 29/00",
        "G01N 33/68",
        "A61K 39/395",
        "A61P 19/02",
        "C12N 15/13",
        "C07K 16/24"
    ]
}